Collective Management of IPR and Patent Pools
UNITAID patent pool for medicines
Cost Benefit Analysis for UNITAID Patent Pool
UNITAIDwebsite on patent pools
MSF website on patent pools
UNITAID patent pool for medicines
Cost Benefit Analysis for UNITAID Patent Pool
UNITAIDwebsite on patent pools
MSF website on patent pools
KEI will host a meeting on the Bilski litigation regarding patents on business methods, on September 10, 2009, from noon to 2:00.
When: Thursday, September 10, 2009 Time: 12:00-2:00pm Location: Knowledge Ecology International (KEI) 1621 Connecticut Ave NW, Suite 500 Washington, DC 20009 Tel +1 202 332 2670The meeting will include presentations by:
James Love and James K. Glassman, Don’t Kill Competition for High-Tech Drugs, Roll Call, Sept. 9, 2009.
KEI Statement on Eshoo/Barton amendment
Some reporting
In May 2009, at the WIPO Standing Committee on Copyright and Related Rights (SCCR) 18th session, the governments of Brazil, Ecuador and Paraguay formally tabled a proposal to WIPO endorsing the World Blind Union’s Treaty for Reading Disabled Persons.
In an August 14, 2009 article in the LA Times, Tom Hamburger provides yet another installment in the ongoing disclosures about a secret White House deal with PhRMA on pharmaceutical pricing.
Thiru Balasubramaniam is the Geneva Representative of Knowledge Ecology International.
On May 25, 2009, Brazil, Ecuador and Paraguay (BEP) submitted a formal proposal at the WIPO SCCR 18, asking that the SCCR consider a proposal for a treaty that was presented to the SCCR in 2008 by the World Blind Union. In 2010, the government of Mexico joined as a co-sponsor of the treaty proposal.
Below is the text of the BEP submission at WIPO:
WIPO STANDING COMMITTEE ON COPYRIGHT AND RELATED RIGHTS
Eighteenth Session Geneva, May 25 to 29, 2009
Continue Reading
KEI has an interest in the general topic of prizes to stimulate innovation, with a special focus on the use of prizes to stimulate medical innovation. The work on medical innovation prizes covers proposals for both high- and lower-income markets, and proposals that target new medical knowledge, as well as product development.
The rollcall for the biosimilars vote in on the Internet here. Based upon the count released by the committee, voting for the Eshoo Amendment were 26 Democrats and 21 Republicans. Voting against were 1 republican (Deal) and 10 Democrats. One Republican did not vote. I have bolded the Nay votes.